Cargando…
New changes in pregnancy and lactation labelling: Review of dermatologic drugs
BACKGROUND: The U.S. Food and Drug Administration has published new pregnancy and lactation labelling rules that set standards on the presentation of information with regard to drug usage during pregnancy and breastfeeding, as well as the effects on fertility. These guidelines became effective June...
Autores principales: | Koh, Yun Pei, Tian, Elizabeth A., Oon, Hazel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831768/ https://www.ncbi.nlm.nih.gov/pubmed/31700976 http://dx.doi.org/10.1016/j.ijwd.2019.05.002 |
Ejemplares similares
-
Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule
por: Byrne, John J., et al.
Publicado: (2020) -
An overview of upcoming changes in pregnancy and lactation labeling information
por: Mosley, Juan F., et al.
Publicado: (2015) -
Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review
por: Tay, Woo Chiao, et al.
Publicado: (2023) -
Understanding the new FDA pregnancy and lactation labeling rules()
por: Blattner, Collin M., et al.
Publicado: (2016) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()()
por: Abrouk, Michael, et al.
Publicado: (2017)